Pharmacokinetics & Pharmacodynamics Flashcards

1
Q

pharmacokinetics

A

how conc. of drug changes in body with time

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

ADME

A

absorption
distribution
metabolism
elimination

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

clinical aim of drug administration

A

achieve effective drug conc. (in therapeutic range) at site of action (systemic circulation) long enough to have an effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

therapeutic window vs index

A

window refers to population while index refers to individual patient
wider box - wider range so safe

used to use LD50 (conc that kills 50% population) divided by ED50 (effective dose)
but not ethical

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

bioavailability

A

proportion of dose of unchanged drug that reaches site of action

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

intravenous injection

A

100% bioavailability because straight to systemic circulation
need sterile equip, trained, expensive, painful

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

oral route (plus and minuses)

A

safest, most convenient, economical, always less than 100% bioavailability because destroyed by bacteria/acid/food/enzymes
absorption depends on rates of passage
some side effects and requires patient co-operation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

drug absorption from GI tract to circulation

A

Fick’s law of passive diffusion

rate = (permeability x SA x conc diff) / thickness of membrane

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what does permeability of drug depend on?

A

its lipid solubility

lipid soluble and small will pass better

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

most drugs are….

and what is better absorbed?

A

weak acids/bases and unionised drugs are better absorbed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

other absorption methods

A

active transport
ion-pair absorption (+ve ion with -ve ion in gut forms neutral complex moves into blood)
pinocytosis engulfs
solvent drug (highly lipid soluble drug won’t dissolve in lumen so dissolve in solvent before drink)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

sites of drug absorption

A

little absorption: small intestine (main site), stomach, colon

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

formulation

A

strong enough so don’t fall apart when handle but still dissolve

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

gut motility

A

gastric emptying modulated by meal size/composition, drugs, physiological state (lay/sit), migraine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

orally administered drugs with potential problems

A

phenoxymethyl penicillin - absorbed by food so take on empty stomach
tetracyclines - absorption reduced by milk/antacids/iron
aspirin - iritate stomach

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

1st pass metabolism

A

before systemic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

if drug rapidly metabolised by liver/gut then other routes?

A

inhalation - avoids 1st pass metabolism, straight to systemic

transdermal - across skin, hard to get across e.g. nicotine patches, ibuprofen gel

buccal+sublingual - gum+under tongue, straight to systemic

intranasal

rectal

subcutaneous - upper dermis not in muscle

intramuscular injection - large blood flow in muscles so reliable route, but can’t self administer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

penicillin administration

A
route affect bioavailability
oral - slow
IV - fast
IM - fast and longer duration
P-IM - modified IM with much longer duration
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

plasma protein binding (function, free drug, what binds what, saturation of binding

A

drugs in plasma bound to proteins which act as buffer/carrier
only free drug is active and eliminated but free can cause toxic effects

weak acids bind plasma albumin
weak bases bind acid glycoprotein

saturation of binding is non linear relationship between dose and free conc.
a small increase in drug conc. causes large increase in free drug so toxic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

tissue distribution of drug depends on….

A

depends on lipid solubility, plasma protein binding and molecular weight
e.g. heparin is big so doesn’t leave plasma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

blood brain barrier

A

hard to get drugs into brain, and it pumps drugs out to have low conc.

because layer of tightly joined endothelial cells, contain P-glycoprotein (Pgp) efflux pump

lipid soluble drugs by passive diffusion
water soluble by carrier mechanisms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

drug metabolism in liver by hepatocytes (what happens, and explain process)

A

some converted to inactive metabolites
some to active metabolites
some excreted unchanged

Phase 1 (primary metabolites): transform molecular structure of drug

Phase 2 (secondary metabolites): conjugation - attachment of endogenous substance to original drug or after phase 1, by transferases

to increase water solubility, make polar, abolish activity

then excretion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

excretion

A

renal route via kidney

can change urinary pH to aid excretion
some drugs actively excreted like penicillin

dangerous if drug excreted unchanged

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

other routes of excretion

A

biliary into intestine - bile to gal bladder to small intestine so can absorb back into blood - enterohepatic circulation

saliva, sweat, tears, expired
breast milk - danger to baby

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Vd
apparent (not real) volume of distribution not real because some conc. of drug in plasma so small that tells you large volume than humans have so just tells you if distributed in tissues or plasma
26
fraction extracted
E= (conc in - conc out)/ conc in
27
clearance
how well gets rid of drug rate of elimination/conc of input volume/time (virtual volume of blood cleared of drug per unit time)
28
creatine clearance rate
linear relationship between drug clearance and creatine clearance so high conc in blood means poor clearance better than taking periodic blood samples to see drug conc change
29
measuring clearance
creatine clearance blood sample renal clearance - urine samples
30
normal clearance for healthy
88-128 mL/min women | 97-137 mL/min male
31
clearance and age
decreases with age so half life of drug goes up and need to adjust dosage intervals
32
first order elimination kinetics (most drugs)
rate of elimination proportional to drug conc. - exponential so faster elimination more drug
33
kel
elimination rate constant units time-1 proportion of drug eliminated per unit time kel= rate of elimination/amount left
34
time constant
1/kel | time taken for conc. to fall 1/e (37%)
35
half life
time taken for drug conc to fall by half ln2/kel helps determine dosage interval
36
2 exponentials of elimination
distribution to other compartments then slower rate elimination both 1st order kinetics
37
Ka
absorption rate constant
38
phases of drug in body
lag time (time to get to blood) absorption (plasma conc builds up) elimination (eliminate/distribute)
39
area under curve of plasma conc (y) against time after ingestion (x)
AUC | bioavailability of drug so amount absorbed
40
loading dose
injection to start then orally maintain level of conc. | better than oral when need immediate effect
41
continuous infusion
slowly build conc. of drug over time (rapid is bad for BP) with infusion/pump to eliminate troughs in oral graph so get smooth curve and eliminate toxicity if use loading dose
42
zero order kinetics
rate of elimination not proportional to drug conc but is constant e.g. ethanol if you start with more drug it takes longer to remove it so half life is not constant but depends on starting conc. so constant amount eliminated
43
drug dosage changes
neonates have reduced body volume and higher proportion of water so reduce dose reduce dose in elderly because higher fat than water, drug binding to plasma proteins reduced low renal function and clearance at birth and reduced in elderly lower metabolism
44
drug monitoring
monitor conc level in blood if toxic/effective take sample at peak conc./trough conc./time above threshold value
45
urine sample to monitor drug
useful so don't need blood and for drugs partially/fully eliminated in urine but volume variable because how much drink so can't use drug conc. but absolute amount (moles)
46
drug modes of action
``` enzyme inhibitors enzyme false substrates receptor activators receptor blockers ion channel blockers ion channel modulators neurotransmitter uptake blockers ```
47
measuring response
force of contraction, current, change in potential, amount of 2nd messenger (cAMP), loss of NT, physiological change
48
EC50
conc that gives 50% of max response
49
why is there a max response?
finite no. receptors so all occupied | or property of tissue/cell so can't contract any more because max reached
50
affinity
how well drug binds receptor (not about the response)
51
efficacy
measure of response - how well turns receptor on to active form low means can't reach max response
52
potency
combine affinity and efficacy
53
k+1 | k-1
association rate constant | dissociation rate constant
54
Kd
conc. of drug required to occupy 50% receptors (k-1)/(k+1) lower Kd means less drug needed so high affinity
55
measuring affinity
can't measure contraction because measures efficacy as well ligand binding assay - radio label ligand and shows when bind to receptor so radioactive shows how much bound but must account for non-specific binding
56
non-specific binding
low affinity so keeps binding and doesn't reach max - straight line saturate with cold ligand (without label) so any radioactivity is binding to non-specific sites so subtract off total binding to get specific binding
57
desensitisation/tachyphylaxis
bound for long time to phosphorylated and receptor internalised so less response because less receptors or run out of mediators tachyphylaxis is whole organ or tissue no longer responds
58
clinical agonists
adrenaline - increase HR and force contraction for anaphylactic shock (allergy) salbutamol for asthma dopamine increase HR morphine for severe pain
59
partial agonsts
partial response same affinity but not full response conc. doesn't matter e.g. to reduce over-activity but not block basal activity, e.g. pain killer or treat addicts
60
basal activity (constitutive)
receptor's activity in absence of ligand
61
partial beta agonists
beta-blockers slow heart but don't block all beta receptors
62
inverse agonists
reduce basal activity of G-protein receptors (reduces response below 0) many antagonists are inverse agonists
63
GABA-A receptor
main inhibitory receptor in brain control excitation 2 binding sites for Gaba, 1 for barbiturates B2 full agonist binds to separate site to increase opening when GABA binds (inverse agonists would bind here and decrease opening)
64
barbiturates
A barbiturate is a drug that acts as a central nervous system depressant and can therefore produce a wide range of effects, from mild sedation to death.
65
competitive antagonists
binds to receptor but doesn't do anything but prevent agonist binding so no response enough agonist can outcompete antagonist don't change max response but shift curve to right because more conc needed for 50% response
66
measurement of potency pA2
-ve log of molar conc. of antagonist that reduces effect of known conc of agonist to that of 1/2 conc. (how good at blocking agonist response) bigger value better antagonist
67
non-competitive antagonists
bind allosteric site or covalently to main site and stay there diff slope gradient and not max response curve none clinically used, but some toxins
68
spare receptors
sometimes don't need to occupy all receptors to get full response (e.g. only 70% needed) use non-competitive antagonists to get full response if still get full response then have spare receptors so conc. for 50% receptors is not conc. for 50% response (Kd not EC50)